Publication | Open Access
<scp>NFAT2</scp> inhibitor ameliorates diabetic nephropathy and podocyte injury in <i>db/db</i> mice
83
Citations
27
References
2013
Year
The NFAT inhibitor 11R-VIVIT might be a useful therapeutic strategy for protecting podocytes and treating DN. The calcinerin/NFAT2/uPA receptor signalling pathway should be exploited as a therapeutic target for protecting podocytes from injury in DN.
| Year | Citations | |
|---|---|---|
Page 1
Page 1